Celgene Shells Out $7.2B For Receptos In A Big Bet On Autoimmune Disease

2020-08-17T21:07:02+00:00Industry News|

Celgene ($CELG) is trading $7.2 billion in cash for Receptos ($RCPT) and its Phase III autoimmune treatment, building on some [...]